Symbols / TAK Stock $15.47 -1.02% Takeda Pharmaceutical Company Limited

Healthcare • Drug Manufacturers - Specialty & Generic • Japan • NYQ
TAK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Christophe P. Weber
Exch · Country NYQ · Japan
Market Cap 48.88B
Enterprise Value 4.93T
Income -152.39B
Sales 4.51T
FCF (ttm) 672.78B
Book/sh 14.57
Cash/sh 188.33
Employees 47,029
Insider 10d —
IPO Jan 05, 2010
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 80.03%
P/E 42.20
Forward P/E 29.19
PEG 0.39
P/S 0.01
P/B 1.06
P/C —
EV/EBITDA 3.99
EV/Sales 1.09
Quick Ratio 0.52
Current Ratio 1.09
Debt/Eq 73.70
LT Debt/Eq —
EPS (ttm) -0.30
EPS next Y 0.53
EPS Growth —
Revenue Growth 3.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2023-07-27
ROA 2.55%
ROE -2.12%
ROIC —
Gross Margin 64.06%
Oper. Margin 11.11%
Profit Margin -3.38%
Shs Outstand 3.16B
Shs Float 3.16B
Insider Own 0.02%
Instit Own 3.14%
Short Float 0.15%
Short Ratio 1.54
Short Interest 4.88M
52W High 18.90
vs 52W High -18.15%
52W Low 12.99
vs 52W Low 19.09%
Beta 0.09
Impl. Vol. 1.56%
Rel Volume 0.72
Avg Volume 3.06M
Volume 2.21M
Target (mean) $20.64
Tgt Median $20.82
Tgt Low $19.27
Tgt High $21.84
# Analysts 3
Recom Strong_buy
Prev Close $15.63
Price $15.47
Change -1.02%
About

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$20.64
Mean price target
2. Current target
$15.47
Latest analyst target
3. DCF / Fair value
$3832.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.47
Low
$19.27
High
$21.84
Mean
$20.64

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-05-16 main TD Cowen Outperform → Outperform $20
2023-04-04 main TD Cowen — → Outperform $30
2023-03-16 up B of A Securities Neutral → Buy $20
2022-07-19 up Cowen & Co. Market Perform → Outperform $24
2021-10-07 down Morgan Stanley Overweight → Equal-Weight —
2020-03-11 main JP Morgan — → Overweight $30
2019-11-01 init Cowen & Co. — → Market Perform $20
2019-09-24 init Jefferies — → Buy —
News
RSS: Latest TAK news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-27 PLUMP ANDREW S. Officer and Director — 212,470 $0.00 $0
2026-04-27 BITETTI TERESA MARIE Officer — 64,988 $0.00 $0
2026-04-27 RICCI GABRIELE Chief Technology Officer — 34,994 $0.00 $0
2026-04-27 PLATFORD GILES RICHARD Officer — 72,124 $0.00 $0
2026-04-27 DUPREY LAUREN RUSCKOWSKI Officer — 59,990 $0.00 $0
2026-04-27 AGOSTI MARCELLO PIGNAGNOLI Officer — 27,740 $0.00 $0
2026-04-27 WEBER CHRISTOPHE PIERRE Chief Executive Officer — 165,370 $0.00 $0
2026-04-27 KIM JULIE SO-YOUNG Officer — 105,416 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Revenue
4,505,720.00
-1.66%
4,581,551.00
+7.45%
4,263,762.00
+5.87%
4,027,478.00
Operating Revenue
4,505,720.00
-1.66%
4,581,551.00
+7.45%
4,263,762.00
+5.87%
4,027,478.00
Cost Of Revenue
1,571,588.00
-0.55%
1,580,217.00
+10.76%
1,426,678.00
+14.68%
1,244,072.00
Reconciled Cost Of Revenue
1,484,005.00
+1.50%
1,462,054.00
+8.24%
1,350,793.00
+20.38%
1,122,115.00
Gross Profit
2,934,132.00
-2.24%
3,001,334.00
+5.79%
2,837,084.00
+1.93%
2,783,406.00
Operating Expense
2,469,681.00
-2.58%
2,534,964.00
+0.31%
2,527,183.00
+15.10%
2,195,594.00
Research And Development
675,924.00
-7.44%
730,227.00
+0.04%
729,924.00
+15.25%
633,325.00
Selling General And Administration
1,084,215.00
-1.86%
1,104,766.00
+4.83%
1,053,819.00
+5.67%
997,309.00
Other Operating Expenses
75,998.00
+33.95%
56,738.00
-37.87%
91,323.00
+305.57%
22,517.00
Total Expenses
4,041,269.00
-1.80%
4,115,181.00
+4.08%
3,953,861.00
+14.95%
3,439,666.00
Operating Income
464,451.00
-0.41%
466,370.00
+50.49%
309,901.00
-47.28%
587,812.00
Total Operating Income As Reported
6,217.00
-98.19%
342,586.00
+60.03%
214,075.00
-56.36%
490,505.00
EBITDA
726,895.00
-32.31%
1,073,791.00
+19.27%
900,328.00
-22.15%
1,156,463.00
Normalized EBITDA
1,187,750.00
-1.06%
1,200,535.00
+17.30%
1,023,446.00
-18.75%
1,259,585.00
Reconciled Depreciation
721,127.00
-5.29%
761,396.00
+4.59%
728,002.00
+9.57%
664,400.00
EBIT
5,768.00
-98.15%
312,395.00
+81.28%
172,326.00
-64.98%
492,063.00
Total Unusual Items
-460,855.00
-263.61%
-126,744.00
-2.95%
-123,118.00
-19.39%
-103,122.00
Total Unusual Items Excluding Goodwill
-460,855.00
-263.61%
-126,744.00
-2.95%
-123,118.00
-19.39%
-103,122.00
Special Income Charges
-466,990.00
-247.60%
-134,347.00
-17.86%
-113,985.00
-4.04%
-109,562.00
Other Special Charges
412,233.00
+3801.87%
10,565.00
-41.82%
18,160.00
-26.21%
24,609.00
Restructuring And Mergern Acquisition
71,824.00
-43.68%
127,531.00
+24.89%
102,115.00
+61.51%
63,225.00
Write Off
1,363.00
-79.99%
6,812.00
+304.27%
1,685.00
-94.50%
30,629.00
Net Income
-152,390.00
-241.20%
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
Pretax Income
-142,355.00
-181.31%
175,084.00
+231.66%
52,791.00
-85.93%
375,090.00
Net Non Operating Interest Income Expense
-143,774.00
+10.45%
-160,554.00
-14.30%
-140,463.00
-13.84%
-123,385.00
Interest Expense Non Operating
148,123.00
+7.87%
137,311.00
+14.87%
119,535.00
+2.19%
116,973.00
Net Interest Income
-143,774.00
+10.45%
-160,554.00
—
-123,385.00
Interest Expense
148,123.00
+7.87%
137,311.00
+14.87%
119,535.00
+2.19%
116,973.00
Interest Income Non Operating
16,878.00
-14.05%
19,638.00
+73.90%
11,293.00
+105.03%
5,508.00
Interest Income
16,878.00
-14.05%
19,638.00
+73.90%
11,293.00
+105.03%
5,508.00
Other Income Expense
-463,032.00
-254.19%
-130,730.00
-12.08%
-116,645.00
-30.57%
-89,336.00
Gain On Sale Of Security
6,135.00
-19.31%
7,603.00
+183.25%
-9,133.00
-241.82%
6,440.00
Gain On Sale Of Business
18,265.00
+79.10%
10,198.00
+30.23%
7,831.00
+15.04%
6,807.00
Tax Provision
9,770.00
-85.41%
66,941.00
+173.23%
-91,406.00
-257.46%
58,052.00
Tax Rate For Calcs
0.00
+4.62%
0.00
+64.80%
0.00
+49.90%
0.00
Tax Effect Of Unusual Items
-184,342.00
-280.41%
-48,458.85
-69.65%
-28,563.38
-78.97%
-15,960.01
Net Income Including Noncontrolling Interests
-152,125.00
-240.67%
108,143.00
-25.00%
144,197.00
-54.52%
317,038.00
Net Income From Continuing Operation Net Minority Interest
-152,390.00
-241.20%
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
Net Income From Continuing And Discontinued Operation
-152,390.00
-241.20%
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
Net Income Continuous Operations
-152,125.00
-240.67%
108,143.00
-25.00%
144,197.00
-54.52%
317,038.00
Minority Interests
-264.00
-22.79%
-215.00
-65.38%
-130.00
-519.05%
-21.00
Normalized Income
124,123.00
-33.34%
186,213.15
-21.96%
238,621.62
-40.96%
404,178.99
Net Income Common Stockholders
-152,390.00
-241.20%
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
Diluted EPS
—
33.62
-26.25%
45.58
-54.86%
100.97
Basic EPS
—
34.18
-25.77%
46.05
-54.92%
102.14
Basic Average Shares
—
3,157.75
+0.92%
3,128.90
+0.81%
3,103.62
Diluted Average Shares
—
3,210.65
+1.58%
3,160.69
+0.67%
3,139.74
Diluted NI Availto Com Stockholders
-152,390.00
-241.20%
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
Amortization
633,544.00
-1.51%
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
Amortization Of Intangibles Income Statement
633,544.00
-1.51%
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
Depreciation Amortization Depletion Income Statement
633,544.00
-1.51%
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
Depreciation And Amortization In Income Statement
633,544.00
-1.51%
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
Earnings From Equity Interest
-2,177.00
+45.38%
-3,986.00
-161.58%
6,473.00
-53.05%
13,786.00
Gain On Sale Of PPE
165.00
-54.55%
363.00
+152.08%
144.00
-93.12%
2,094.00
Total Other Finance Cost
12,529.00
-70.78%
42,881.00
+33.08%
32,221.00
+170.31%
11,920.00
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Assets
15,511,506.00
+8.87%
14,248,344.00
-5.70%
15,108,792.00
+8.25%
13,957,750.00
Current Assets
3,090,503.00
+22.58%
2,521,192.00
-1.46%
2,558,580.00
+6.70%
2,397,956.00
Cash Cash Equivalents And Short Term Investments
636,942.00
+57.04%
405,589.00
-14.23%
472,889.00
-14.60%
553,704.00
Cash And Cash Equivalents
595,054.00
+54.51%
385,113.00
-15.88%
457,800.00
-14.19%
533,530.00
Cash Equivalents
450,294.00
+197.48%
151,371.00
-40.08%
252,611.00
-16.90%
303,973.00
Cash Financial
144,760.00
-38.07%
233,742.00
+13.91%
205,190.00
-10.61%
229,557.00
Other Short Term Investments
41,888.00
+104.57%
20,476.00
+35.70%
15,089.00
-25.21%
20,174.00
Receivables
876,348.00
+20.83%
725,254.00
+3.96%
697,610.00
+2.33%
681,694.00
Accounts Receivable
977,355.00
+26.78%
770,896.00
+7.27%
718,675.00
+6.52%
674,691.00
Receivables Adjustments Allowances
-169,330.00
-41.72%
-119,481.00
-12.47%
-106,236.00
-7.03%
-99,260.00
Other Receivables
36,287.00
-37.49%
58,050.00
+3.73%
55,964.00
-24.37%
73,999.00
Taxes Receivable
32,036.00
+102.90%
15,789.00
-45.94%
29,207.00
-9.47%
32,264.00
Inventory
1,396,620.00
+14.73%
1,217,349.00
+0.62%
1,209,869.00
+22.65%
986,457.00
Raw Materials
328,685.00
-3.79%
341,636.00
+1.19%
337,612.00
+20.19%
280,908.00
Work In Process
641,002.00
+16.08%
552,200.00
+5.65%
522,667.00
+19.74%
436,508.00
Finished Goods
426,933.00
+31.97%
323,513.00
-7.46%
349,590.00
+29.94%
269,042.00
Assets Held For Sale Current
17,955.00
+34.02%
13,397.00
+43.48%
9,337.00
-38.71%
15,235.00
Other Current Assets
162,638.00
+1.90%
159,603.00
-5.49%
168,875.00
+4.98%
160,866.00
Total Non Current Assets
12,421,004.00
+5.92%
11,727,152.00
-6.56%
12,550,214.00
+8.57%
11,559,794.00
Net PPE
2,120,639.00
+7.74%
1,968,209.00
-1.08%
1,989,777.00
+17.65%
1,691,229.00
Gross PPE
3,652,509.00
+11.59%
3,273,239.00
+1.95%
3,210,478.00
+18.95%
2,698,983.00
Accumulated Depreciation
-1,531,870.00
-17.38%
-1,305,030.00
-6.91%
-1,220,701.00
-21.13%
-1,007,754.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
108,774.00
+4.25%
104,342.00
-1.42%
105,845.00
+7.76%
98,227.00
Buildings And Improvements
1,836,073.00
+9.82%
1,671,876.00
-0.43%
1,679,054.00
+19.92%
1,400,108.00
Machinery Furniture Equipment
1,312,774.00
+11.69%
1,175,365.00
+2.48%
1,146,889.00
+15.47%
993,249.00
Construction In Progress
394,889.00
+22.77%
321,656.00
+15.42%
278,689.00
+34.37%
207,400.00
Goodwill And Other Intangible Assets
9,228,358.00
+3.04%
8,955,990.00
-7.52%
9,684,750.00
+6.89%
9,060,380.00
Goodwill
5,809,010.00
+9.10%
5,324,430.00
-1.58%
5,410,067.00
+12.93%
4,790,723.00
Other Intangible Assets
3,419,348.00
-5.84%
3,631,560.00
-15.04%
4,274,683.00
+0.12%
4,269,657.00
Investments And Advances
448,737.00
+23.99%
361,926.00
-15.95%
430,608.00
+13.66%
378,857.00
Long Term Equity Investment
8,796.00
-18.57%
10,802.00
-87.98%
89,831.00
-9.42%
99,174.00
Non Current Deferred Assets
546,260.00
+47.34%
370,745.00
-5.87%
393,865.00
+7.61%
366,003.00
Non Current Deferred Taxes Assets
546,260.00
+47.34%
370,745.00
-5.87%
393,865.00
+7.61%
366,003.00
Other Non Current Assets
77,010.00
+9.57%
70,282.00
+37.23%
51,214.00
-19.13%
63,325.00
Total Liabilities Net Minority Interest
8,080,857.00
+10.51%
7,312,365.00
-6.67%
7,834,787.00
+3.05%
7,603,079.00
Current Liabilities
2,832,074.00
+12.99%
2,506,521.00
+8.36%
2,313,103.00
-6.80%
2,481,940.00
Payables And Accrued Expenses
589,225.00
-3.25%
609,038.00
-7.36%
657,427.00
-25.43%
881,610.00
Payables
589,225.00
-3.25%
609,038.00
-7.36%
657,427.00
-25.43%
881,610.00
Accounts Payable
324,368.00
+5.16%
308,450.00
-3.60%
319,955.00
+4.07%
307,453.00
Other Payable
166,977.00
-0.07%
167,091.00
-26.57%
227,566.00
-33.42%
341,780.00
Employee Benefits
143,683.00
+6.09%
135,429.00
-5.87%
143,882.00
+12.77%
127,594.00
Total Tax Payable
97,880.00
-26.68%
133,497.00
+21.46%
109,906.00
-52.70%
232,377.00
Income Tax Payable
97,880.00
-26.68%
133,497.00
+21.46%
109,906.00
-52.70%
232,377.00
Current Debt And Capital Lease Obligation
512,157.00
-6.70%
548,939.00
+49.47%
367,251.00
+8.14%
339,600.00
Current Debt
512,157.00
-6.70%
548,939.00
+49.47%
367,251.00
+8.14%
339,600.00
Other Current Borrowings
512,157.00
-6.70%
548,939.00
+49.47%
367,251.00
+8.14%
339,600.00
Other Current Liabilities
732,191.00
-10.21%
815,404.00
+6.73%
764,005.00
+1.55%
752,370.00
Total Non Current Liabilities Net Minority Interest
5,248,783.00
+9.22%
4,805,844.00
-12.96%
5,521,684.00
+7.82%
5,121,139.00
Long Term Debt And Capital Lease Obligation
4,369,681.00
+10.17%
3,966,326.00
-11.40%
4,476,501.00
+10.73%
4,042,741.00
Long Term Debt
4,369,681.00
+10.17%
3,966,326.00
-11.40%
4,476,501.00
+10.73%
4,042,741.00
Long Term Provisions
37,550.00
+6.75%
35,177.00
+144.74%
14,373.00
-74.32%
55,969.00
Non Current Pension And Other Postretirement Benefit Plans
143,683.00
+6.09%
135,429.00
-5.87%
143,882.00
+12.77%
127,594.00
Tradeand Other Payables Non Current
—
317.00
-92.76%
4,381.00
-82.16%
24,558.00
Non Current Deferred Liabilities
26,804.00
-23.75%
35,153.00
-69.10%
113,777.00
-57.96%
270,620.00
Non Current Deferred Taxes Liabilities
26,804.00
-23.75%
35,153.00
-69.10%
113,777.00
-57.96%
270,620.00
Other Non Current Liabilities
671,065.00
+5.89%
633,759.00
-17.56%
768,770.00
+28.20%
599,657.00
Stockholders Equity
7,429,441.00
+7.13%
6,935,084.00
-4.65%
7,273,264.00
+14.47%
6,354,122.00
Common Stock Equity
7,429,441.00
+7.13%
6,935,084.00
-4.65%
7,273,264.00
+14.47%
6,354,122.00
Capital Stock
1,695,277.00
+0.03%
1,694,685.00
+1.08%
1,676,596.00
+0.01%
1,676,345.00
Common Stock
1,695,277.00
+0.03%
1,694,685.00
+1.08%
1,676,596.00
+0.01%
1,676,345.00
Share Issued
1,591.23
+0.02%
1,590.95
+0.54%
1,582.42
+0.01%
1,582.30
Ordinary Shares Number
1,579.84
+0.39%
1,573.65
+0.30%
1,569.01
+0.93%
1,554.53
Treasury Shares Number
11.39
-34.15%
17.30
+29.05%
13.41
-51.72%
27.77
Additional Paid In Capital
1,776,352.00
+0.04%
1,775,713.00
+1.62%
1,747,414.00
+1.07%
1,728,830.00
Retained Earnings
712,381.00
-40.01%
1,187,586.00
-14.64%
1,391,203.00
-9.73%
1,541,146.00
Gains Losses Not Affecting Retained Earnings
-2,848.00
0.00
—
—
Treasury Stock
49,128.00
-34.33%
74,815.00
+45.95%
51,259.00
-48.90%
100,317.00
Minority Interest
1,208.00
+34.97%
895.00
+20.78%
741.00
+34.97%
549.00
Other Equity Adjustments
-2,848.00
—
—
—
Total Equity Gross Minority Interest
7,430,649.00
+7.13%
6,935,979.00
-4.65%
7,274,005.00
+14.47%
6,354,671.00
Total Capitalization
11,799,122.00
+8.23%
10,901,410.00
-7.22%
11,749,765.00
+13.01%
10,396,863.00
Working Capital
258,429.00
+1661.50%
14,671.00
-94.02%
245,477.00
+392.29%
-83,984.00
Invested Capital
12,311,279.00
+7.52%
11,450,349.00
-5.50%
12,117,016.00
+12.86%
10,736,463.00
Total Debt
4,881,838.00
+8.12%
4,515,265.00
-6.78%
4,843,752.00
+10.53%
4,382,341.00
Net Debt
4,286,784.00
+3.79%
4,130,152.00
-5.83%
4,385,952.00
+13.96%
3,848,811.00
Net Tangible Assets
-1,798,917.00
+10.98%
-2,020,906.00
+16.20%
-2,411,486.00
+10.89%
-2,706,258.00
Tangible Book Value
-1,798,917.00
+10.98%
-2,020,906.00
+16.20%
-2,411,486.00
+10.89%
-2,706,258.00
Available For Sale Securities
439,941.00
+25.30%
351,124.00
+3.04%
340,777.00
+21.84%
279,683.00
Current Provisions
998,501.00
+87.29%
533,140.00
+1.66%
524,420.00
+3.16%
508,360.00
Investmentin Financial Assets
439,941.00
+25.30%
351,124.00
+3.04%
340,777.00
+21.84%
279,683.00
Other Equity Interest
3,297,407.00
+40.20%
2,351,915.00
-6.27%
2,509,310.00
+66.39%
1,508,118.00
Other Inventories
—
—
—
-1.00
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Operating Cash Flow
1,041,431.00
-1.49%
1,057,182.00
+47.58%
716,344.00
-26.69%
977,156.00
Cash Flow From Continuing Operating Activities
1,041,432.00
-1.49%
1,057,181.00
+47.58%
716,344.00
-26.69%
977,157.00
Net Income From Continuing Operations
-152,125.00
-240.67%
108,143.00
-25.00%
144,197.00
-54.52%
317,038.00
Depreciation Amortization Depletion
721,127.00
-5.29%
761,396.00
+4.59%
728,002.00
+9.57%
664,400.00
Depreciation And Amortization
721,127.00
-5.29%
761,396.00
+4.59%
728,002.00
+9.57%
664,400.00
Other Non Cash Items
99,112.00
-32.79%
147,465.00
-28.68%
206,773.00
+1048.36%
18,006.00
Stock Based Compensation
72,775.00
-0.13%
72,867.00
+2.82%
70,871.00
+16.81%
60,672.00
Asset Impairment Charge
145,716.00
+36.79%
106,529.00
-28.99%
150,017.00
+132.97%
64,394.00
Deferred Tax
9,770.00
-85.41%
66,941.00
+173.23%
-91,406.00
-257.46%
58,052.00
Deferred Income Tax
9,770.00
-85.41%
66,941.00
+173.23%
-91,406.00
-257.46%
58,052.00
Operating Gains Losses
116,707.00
+2660.34%
4,228.00
+107.71%
-54,825.00
-3091.00%
1,833.00
Gain Loss On Investment Securities
129,727.00
+2082.12%
5,945.00
+112.77%
-46,572.00
—
Unrealized Gain Loss On Investment Securities
1,006.00
+267.11%
-602.00
-102.90%
20,757.00
+420.10%
3,991.00
Gain Loss On Sale Of PPE
3,068.00
-31.75%
4,495.00
-25.73%
6,052.00
+60420.00%
10.00
Change In Working Capital
199,905.00
+436.70%
-59,372.00
+76.81%
-256,003.00
-913.31%
-25,264.00
Change In Receivables
-70,166.00
-19.01%
-58,959.00
-490.35%
15,104.00
-79.90%
75,127.00
Change In Inventory
-61,293.00
-75.26%
-34,973.00
+69.78%
-115,743.00
-46.22%
-79,155.00
Change In Payables And Accrued Expense
-3,150.00
+55.75%
-7,118.00
+28.06%
-9,895.00
+88.33%
-84,804.00
Change In Payable
-3,150.00
+55.75%
-7,118.00
+28.06%
-9,895.00
+88.33%
-84,804.00
Change In Other Working Capital
416,120.00
+821.31%
45,166.00
+135.59%
-126,901.00
-497.82%
31,899.00
Change In Other Current Liabilities
-81,606.00
-2239.62%
-3,488.00
+81.21%
-18,568.00
-158.63%
31,669.00
Investing Cash Flow
-369,141.00
-0.57%
-367,060.00
+20.87%
-463,862.00
+23.59%
-607,102.00
Cash Flow From Continuing Investing Activities
-369,141.00
-0.57%
-367,061.00
+20.87%
-463,861.00
+23.59%
-607,102.00
Net PPE Purchase And Sale
-169,549.00
+15.53%
-200,717.00
-20.32%
-166,814.00
-19.41%
-139,695.00
Purchase Of PPE
-176,003.00
+12.35%
-200,795.00
-14.47%
-175,420.00
-24.71%
-140,657.00
Sale Of PPE
6,454.00
+8174.36%
78.00
-99.09%
8,606.00
+794.59%
962.00
Capital Expenditure
-414,659.00
-9.23%
-379,625.00
+21.03%
-480,730.00
+24.14%
-633,689.00
Net Investment Purchase And Sale
-10,400.00
+87.31%
-81,941.00
-155.71%
-32,045.00
-364.77%
12,103.00
Purchase Of Investment
-17,431.00
+84.35%
-111,383.00
-178.00%
-40,066.00
-294.70%
-10,151.00
Sale Of Investment
7,031.00
-76.12%
29,442.00
+267.06%
8,021.00
-63.96%
22,254.00
Net Business Purchase And Sale
33,582.00
-56.52%
77,243.00
+287.01%
19,959.00
+150.80%
7,958.00
Purchase Of Business
-623.00
+37.95%
-1,004.00
0.00
0.00
Gain Loss On Sale Of Business
-18,265.00
-79.10%
-10,198.00
-30.21%
-7,832.00
-15.06%
-6,807.00
Net Intangibles Purchase And Sale
-238,656.00
-33.45%
-178,830.00
+41.43%
-305,310.00
+38.08%
-493,032.00
Purchase Of Intangibles
-238,656.00
-33.45%
-178,830.00
+41.43%
-305,310.00
+38.08%
-493,032.00
Net Other Investing Changes
-2,775.00
-150.00%
-1,110.00
+72.28%
-4,004.00
-31.19%
-3,052.00
Financing Cash Flow
-496,820.00
+33.88%
-751,425.00
-112.02%
-354,416.00
+50.02%
-709,148.00
Cash Flow From Continuing Financing Activities
-496,819.00
+33.88%
-751,423.00
-112.02%
-354,415.00
+50.02%
-709,149.00
Net Issuance Payments Of Debt
1,076.00
+100.34%
-314,314.00
-20874.22%
1,513.00
+100.53%
-285,071.00
Issuance Of Debt
586,060.00
-44.29%
1,051,950.00
+179.03%
377,000.00
+227.83%
115,000.00
Repayment Of Debt
-584,984.00
+57.18%
-1,366,264.00
-263.86%
-375,487.00
+6.14%
-400,071.00
Long Term Debt Issuance
586,060.00
-42.79%
1,024,460.00
+924.46%
100,000.00
+33.33%
75,000.00
Long Term Debt Payments
-243,204.00
+82.20%
-1,366,264.00
-263.86%
-375,487.00
+6.14%
-400,071.00
Net Long Term Debt Issuance
342,856.00
+200.31%
-341,804.00
-24.07%
-275,487.00
+15.25%
-325,071.00
Short Term Debt Issuance
—
27,490.00
-90.08%
277,000.00
+592.50%
40,000.00
Short Term Debt Payments
-341,780.00
—
—
—
Net Short Term Debt Issuance
-341,780.00
-1343.29%
27,490.00
-90.08%
277,000.00
+592.50%
40,000.00
Net Common Stock Issuance
-51,603.00
+0.50%
-51,860.00
-2129.58%
-2,326.00
+91.36%
-26,929.00
Common Stock Payments
-51,603.00
+0.50%
-51,860.00
-2129.58%
-2,326.00
+91.36%
-26,929.00
Common Stock Dividend Paid
—
—
—
-279,416.00
Cash Dividends Paid
-311,901.00
-3.11%
-302,498.00
-5.33%
-287,188.00
-2.78%
-279,416.00
Repurchase Of Capital Stock
-51,603.00
+0.50%
-51,860.00
-2129.58%
-2,326.00
+91.36%
-26,929.00
Net Other Financing Charges
-13,012.00
-143.04%
30,231.00
-10.98%
33,960.00
+470.06%
-9,177.00
Changes In Cash
175,469.00
+386.24%
-61,302.00
+39.86%
-101,934.00
+69.94%
-339,094.00
Effect Of Exchange Rate Changes
34,472.00
+402.78%
-11,385.00
-143.45%
26,204.00
+14.28%
22,929.00
Beginning Cash Position
385,113.00
-15.88%
457,800.00
-14.19%
533,530.00
-37.21%
849,695.00
End Cash Position
595,054.00
+54.51%
385,113.00
-15.88%
457,800.00
-14.19%
533,530.00
Free Cash Flow
626,772.00
-7.50%
677,557.00
+187.57%
235,614.00
-31.40%
343,467.00
Dividends Received CFI
1,298.00
+104.41%
635.00
-95.19%
13,191.00
+270.33%
3,562.00
Earnings Losses From Equity Investments
2,177.00
-45.38%
3,986.00
+161.58%
-6,473.00
-175.01%
8,630.00
Interest Paid CFF
-121,380.00
-7.43%
-112,984.00
-12.56%
-100,375.00
+7.54%
-108,555.00
Interest Received CFI
17,359.00
-1.70%
17,660.00
+58.23%
11,161.00
+120.83%
5,054.00
Sale Of Business
34,205.00
-56.29%
78,247.00
+292.04%
19,959.00
+150.80%
7,958.00
Taxes Refund Paid
-172,562.00
-14.73%
-150,413.00
+25.55%
-202,039.00
-8.64%
-185,966.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category